United States stem cells research boundaries
Author(s)
Elichabe, Benoît
DownloadFull printable version (5.357Mb)
Alternative title
US stem cells research boundaries
Other Contributors
Sloan School of Management.
Advisor
Fiona Murray.
Terms of use
Metadata
Show full item recordAbstract
Recent empirical work has demonstrated the importance of a number of elements of scientific infrastructure that seem to be crucial particularly in fields such as molecular and cellular biology in which the materiality of research renders the process of replication and validation more complex. Scientific infrastructure has many interconnecting elements such as the ability to exchange material used in experiments, the ability to share ideas and information and the ability to share, exchange and promote the mobility of researchers. We focus our investigation on stem cell research in the United States (US). Research in human developmental biology has led to the discovery of human stem cells. The science of stem cell therapies is about to enter a phase of research and development that could lead to unprecedented cures and palliative treatments. However, it is a highly regulated field of research and it raises an important amount of moral, religious and ethical concerns. We seek to examine the boundaries that have emerged in the US in this particular field and we try to understand their impact on the US market of fertilized eggs, embryos and human embryonic stem cells.
Description
Thesis (M.B.A.)--Massachusetts Institute of Technology, Sloan School of Management, 2007. Includes bibliographical references (leaves [88]-90).
Date issued
2007Department
Sloan School of ManagementPublisher
Massachusetts Institute of Technology
Keywords
Sloan School of Management.